These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 13428892)

  • 1. Effect of 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide (diamox) on dental caries resistance in hamsters.
    MITCHELL DF; JOHNSON MJ
    J Dent Res; 1957 Jun; 36(3):372-4. PubMed ID: 13428892
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of the carbonic anhydrase inhibitor 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide (acetazolamide) on citric acid excretion in the urine].
    OTTO H
    Klin Wochenschr; 1958 Jul; 36(13):633-6. PubMed ID: 13564739
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clearance tests of kidney function in patients treated with 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide (diamox)].
    REITANO U; BONANNO S
    Riforma Med; 1955 Oct; 69(40):1097-105. PubMed ID: 13267313
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of cerebrospinal fluid formation by a carbonic anhydrase inhibitor, 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide (diamox).
    TSCHIRGI RD; FROST RW; TAYLOR JL
    Proc Soc Exp Biol Med; 1954 Nov; 87(2):373-6. PubMed ID: 13237248
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of 2-acetylamino-1, 3, 4-thiadiazole-5-sulfonamide (6063:Diamox) on the secretion of gastric hydrochloric acid in man (a preliminary report).
    MCGOWAN JA; STANLEY MM; POWELL JJ
    Bull New Engl Med Cent; 1952; 14(4):117-21. PubMed ID: 13009390
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of pancreatic secretion by the carbonic anhydrase inhibitor 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide, diamox (#6063).
    BIRNBAUM D; HOLLANDER F
    Am J Physiol; 1953 Aug; 174(2):191-5. PubMed ID: 13080429
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide (diamox) on sodium, potassium, bicarbonate and buffer content of saliva.
    NIEDERMEIER W; STONE RE; DREIZEN S; SPIES TD
    Proc Soc Exp Biol Med; 1955 Feb; 88(2):273-5. PubMed ID: 14357412
    [No Abstract]   [Full Text] [Related]  

  • 8. Carbonic anhydrase inhibition. V. N5-substituted 2-acetylamino-1,3,4-thiadiazole-5-sulfonamides: metabolic conversion and use as control substances.
    MAREN TH
    J Pharmacol Exp Ther; 1956 Aug; 117(4):385-401. PubMed ID: 13358050
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of gastric secretion of acid in dogs by carbonic anhydrase inhibitor, 2-acetylamino-1, 3, 4-thiadiazole-5-sulfonamide.
    JANOWITZ HD; COLCHER H; HOLLANDER F
    Am J Physiol; 1952 Nov; 171(2):325-30. PubMed ID: 13007797
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical uses of 5-acetamido-1, 3, 4-thiadiazole-2-sulfonamide (diamox)].
    COCCHI P
    Riv Clin Pediatr; 1955 Aug; 56(2):204-7. PubMed ID: 13290578
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of intravenously administered 6063, the carbonic anhydrase inhibitor, 2-acetylamino-1, 3, 4-thiadiazole-5-sulfonamide, on fluid and electrolytes in normal subjects and patients with congestive heart failure.
    FRIEDBERG CK; HALPERN M; TAYMOR R
    J Clin Invest; 1952 Dec; 31(12):1074-81. PubMed ID: 13011199
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of pancreatic secretion by the carbonic anhydrase inhibitor, 2-acetylamino-1,3,4, thiadiazole-5-sulfonamide (compound No. 6063).
    BIRNBAUM D; HOLLANDER F
    Proc Soc Exp Biol Med; 1952 Oct; 81(1):23-4. PubMed ID: 13047303
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticonvulsant activity of analogues of acetazolamide.
    Chufán EE; Pedregosa JC; Baldini ON; Bruno-Blanch L
    Farmaco; 1999; 54(11-12):838-41. PubMed ID: 10668186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Variations of urinary pH of R.A. during 2-acetamido-1, 3, 4-thiadiazole-6-sulfonamide (diamox) therapy of cardiac insufficiency].
    CORDOVA C; PALMA G; ANDREUCCI G; COSTA C
    Minerva Med; 1955 Sep; 46(78):767. PubMed ID: 13272619
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal effects and inhibition of renal effects by administration of different doses of 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide; response to the subsequent administration of ammonium chloride and alkalies.
    DURAND P; BRUNI R; SORARU' E; CUSMANO F; DE MARCO B
    Helv Paediatr Acta; 1955 May; 10(1-2):199-204. PubMed ID: 13241956
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of two topical application methods used to assess the anti-dental caries potential of drugs in hamsters.
    Keyes PH
    J Oral Ther Pharmacol; 1966 Jan; 2(4):285-94. PubMed ID: 5902254
    [No Abstract]   [Full Text] [Related]  

  • 17. [Behavior of urinary and hematic electrolytes during the administration of 5-acetamido-1,3,4-thiadiazole-2-sulfonamide in cardiac insufficiency].
    PALMA G; CORDOVA C; COSTA C; ANDREUCCI G
    Minerva Med; 1955 Sep; 46(77):728-9. PubMed ID: 13265364
    [No Abstract]   [Full Text] [Related]  

  • 18. Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of 5-amino-1,3,4-thiadiazole-2-sulfonamide and 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide to human isoform II.
    Menchise V; De Simone G; Di Fiore A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6204-8. PubMed ID: 17000110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The teratological effect of certain thiadiazoles related to acetazolamide, with a note on sulfanilamide and thiazide diuretics.
    Maren TH; Ellison AC
    Johns Hopkins Med J; 1972 Feb; 130(2):95-104. PubMed ID: 5066787
    [No Abstract]   [Full Text] [Related]  

  • 20. [S-Sulfanilamido- and 3-sulfanilamido-1,2,4-thiadiazole].
    WOERFFEL U; BEHNISCH R
    Arch Pharm Ber Dtsch Pharm Ges; 1962 Nov; 295/67():811-6. PubMed ID: 14001457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.